OKUR - Wutah bathi EPS kuartalan OnKure Therapeutics

Lambang korporat lan logo OnKure (OKUR)

The quarterly earnings per share trend for OnKure Therapeutics Inc (OKUR) demonstrates the impact of patents on targeted inhibitors, which have created a defensive barrier for margins. The 67.70 mark records this metric, highlighting the business's financial status. Formula development has been delegated to external contractors, while experienced scientists manage the biotech operations, transparently allocating venture investments into clinical phases.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan OnKure Therapeutics (OKUR): kanggo periode 08.10.2024 - 18.11.2026

OKUR (OnKure Therapeutics, Inc.): rincian analitis lan laporan miturut indikator

- nilai pasar lan prakiraan target analis:
Analisis wiwitan perusahaan:OnKure Therapeutics Inc
Produk asil prodhuksi OnKure Therapeutics

For OnKure Therapeutics Inc (OKUR), whose revenue is constrained by strict clinical trial protocols and FDA decisions, this indicator reflects the monetization efficiency of targeted oncology. The quarterly EPS growth trend measures the percentage change in net income per share relative to the previous period, allowing investors to assess the sustainability of the business model and promptly identify the risk of profit stagnation during a shift in the regulatory cycle.

Karo sapa OnKure Therapeutics Inc saingan

ONC: Wutah bathi EPS kuartalan|Halozyme Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|RVMD (Revolution Medicines Inc) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Ascentage Pharma Group AAPG|Wutah bathi EPS kuartalan CGON|Wutah bathi EPS kuartalan UroGen Pharma Ltd (URGN)|Wutah bathi EPS kuartalan BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Erasca Oncology - Wutah bathi EPS kuartalan|DCTH: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|YMAB: Wutah bathi EPS kuartalan|Aura Bio (AURA) - Wutah bathi EPS kuartalan|CADL (Candel Therapeutics Inc.) - Wutah bathi EPS kuartalan|ARAY: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SLS (SELLAS Life Sciences Group, Inc.)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ACTU|Citius Oncology - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan HURA|TARA: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Fate Pharma|Aadi Bioscience Inc (WHWK) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan TScan (TCRX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CSBR|xbiotech.com (XBIT) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cel-sci.com (CVM)|OSTX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Radiopharm Theranostics - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ARTV|ANL - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|VERU - Wutah bathi EPS kuartalan|Tempest Therapeutics, Inc. (TPST) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|XLO: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|RENB (Renovaro Biosciences) - Wutah bathi EPS kuartalan|MURA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan KAPA (Kairos Pharma Ltd)|Wutah bathi EPS kuartalan CytoMed (GDTC)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan curis.com CRIS|APLM (Apollomics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Tharimmune Corporation - Wutah bathi EPS kuartalan|ADVB (advanbiomed.com) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Genprex, Inc (GNPX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CLDI: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|SBFM (Sunshine Biopharma, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan XBIO (Xenetic Biosciences)|Wutah bathi EPS kuartalan SLRX|Purple Biotech - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|American Oncology Network - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan BGNE|CKPT - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Elevation Oncology (ELEV) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ICAD: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Viracta Therapeutics (VIRX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan AAPGV (Ascentage)